Cargando…
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
BACKGROUND: In many clinical trials designed to assess the efficacy of anticancer treatments, overall survival (OS) is often used as a primary endpoint despite its several points of weakness. METHODS: This study evaluated the role of progression-free survival (PFS) in the first three lines of treatm...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975605/ https://www.ncbi.nlm.nih.gov/pubmed/29872317 http://dx.doi.org/10.2147/OTT.S151276 |